Table 1

Baseline Patient Characteristics (n = 50)

Age, yrs74.8 (38–91)
Male30 (60.0)
Coronary heart disease39 (78.0)
Atrial fibrillation35 (70.0)
Hypertension40 (80.0)
Smoker10 (20.0)
Hyperlipoproteinemia28 (56.0)
Diabetes21 (42.0)
NYHA functional class 3–444 (88.0)
Renal insufficiency34 (68.0)
LVEDD54.6 ± 8.3
LV function, %
 ≤3525 (50.0)
 36–5017 (30.0)
 >5010 (20.0)
Regurgitation etiology
 Functional23 (46.0)
 Degenerative15 (30.0)
 Mixed12 (24.0)
Beta-blockers48 (96.0)
Aldosterone antagonist31 (62.0)
ACE inhibitors/sartans47 (94.0)
Diuretic agents46 (92.0)
Digitalis4 (8.0)
Calcium antagonists7 (14.3)
Anticoagulation37 (74.0)

Values are mean (range), n (%), mean ± SD.

ACE = angiotensin-converting enzyme; LV = left ventricular; LVEDD = left ventricular end-diastolic diameter; NYHA = New York Heart Association.